Position in GRFS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$107,191
-$14,680 QoQ
Shares Held
15,140
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#94
of 164 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sowell Financial Services LLC holds $62,788,240 across 14 Drug Manufacturers - General names. GRFS ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
57,238 | $14,536,734 | |
| 2 | ABBV |
AbbVie Inc.
|
44,316 | $11,151,678 | |
| 3 | MRK |
Merck & Co., Inc.
|
75,015 | $9,639,427 | |
| 4 | LLY |
ELI LILLY & Co
|
7,621 | $9,140,856 | |
| 5 | PFE |
Pfizer Inc
|
185,807 | $4,474,232 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
68,220 | $3,930,836 | |
| 7 | AMGN |
Amgen Inc
|
10,762 | $3,897,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,103 | $1,908,113 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,191 | 15,140 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $121,871 | 15,196 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $147,767 | 15,804 | Shares | Sole | 2026-01-21 | |
| 2021-03-31 | $6,881 | 398 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,974 | 324 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $5,621 | 324 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,238 | 342 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $29,203 | 1,450 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||